The pediatric hematology/oncology nurse should have an understanding of how children,
adolescents, and young adults with hematologic and oncologic diseases can access the
HPV vaccine.
Support of Future Research
APHON recognizes the need for continued research regarding the HPV vaccine to: 1)
determine the immunogenicity of the vaccine in cancer survivors to ensure the vaccine affords
these survivors adequate protection against HPV and 2) increase the low uptake of HPV
vaccination in the population of children, adolescents, and young adults with hematologic and
oncologic diseases.
Summary
PAYA with hematologic and oncologic disorders are missing opportunities to receive the
HPV vaccine, and vaccination uptake in this population is low. Pediatric hematology/oncology
nurses have the opportunity to promote HPV vaccination among PAYA hematology/oncology
patients and have the responsibility to discuss cancer prevention strategies, including the HPV
vaccine, with their patients. APHON supports the promotion of the HPV vaccine as a crucial part
of clinical practice for pediatric hematology/oncology nurses.
Powered by FlippingBook